<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/285b–9" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/285b–9/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/285b–9/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_285b_9"><akn:num>285b–9</akn:num><akn:heading>HHS valvular heart disease activities</akn:heading><akn:content><akn:p>§ 285b–9. HHS valvular heart disease activities(a) In generalThe Secretary of Health and Human Services (referred to in this section as the “Secretary”) shall, as appropriate, continue activities related to research, education, and awareness of valvular heart diseases.


(b) NIH research related to valvular heart diseases(1) In generalThe Director of the National Institutes of Health, in consultation with the Director of the National Heart, Lung, and Blood Institute, may support or conduct research regarding valvular heart diseases.


(2) Support further researchIn order to improve information on, and understanding of, causation and risk factors for valvular heart diseases, research conducted or supported under this subsection for such diseases may include the following:(A) Use of advanced technological imaging and other relevant methods to generate data related to valvular heart diseases.

(B) Assessing potential risk factors for sudden cardiac arrest or sudden cardiac death from valvular heart diseases.

(C) Other activities, as appropriate, in order to improve the availability of information on, and advance research related to, valvular heart diseases.


(3) Mitral valve prolapse workshopNot later than 2 years after December 20, 2022, the Director of the National Heart, Lung, and Blood Institute shall, as appropriate, convene a workshop composed of subject matter experts and stakeholders to identify research needs and opportunities to develop recommendations for the identification and treatment of individuals with mitral valve prolapse, including such individuals who may be at risk for sudden cardiac arrest or sudden cardiac death.



(c) Prevention activities to improve awareness of sudden cardiac death as a result of valvular heart diseases(1) In generalThe Secretary may carry out activities to increase education and awareness of valvular heart diseases in order to reduce the incidence of sudden cardiac death caused by such diseases. The Secretary may—(A) award</akn:p></akn:content><akn:subsection eId="subsec_285b_9_a"><akn:num>(a)</akn:num><akn:heading>In general</akn:heading><akn:content><akn:p>(a) In general The Secretary of Health and Human Services (referred to in this section as the “Secretary”) shall, as appropriate, continue activities related to research, education, and awareness of valvular heart diseases.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_285b_9_b"><akn:num>(b)</akn:num><akn:heading>NIH research related to valvular heart diseases</akn:heading><akn:content><akn:p>(b) NIH research related to valvular heart diseases</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_285b_9_c"><akn:num>(c)</akn:num><akn:heading>Prevention activities to improve awareness of sudden cardiac death as a result of valvular heart diseases</akn:heading><akn:content><akn:p>(c) Prevention activities to improve awareness of sudden cardiac death as a result of valvular heart diseases</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_285b_9_d"><akn:num>(d)</akn:num><akn:heading>Authorization of appropriations</akn:heading><akn:content><akn:p>(d) Authorization of appropriations For purposes of carrying out this section, there are authorized to be appropriated $28,000,000 for each of fiscal years 2023 through 2027.</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>